SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Global X Funds - Global X Defense Tech ETF

Global X Defense Tech ETF

The Global X Defense Tech ETF (SHLD) is trending as investors capitalize on surging global military spending and geopolitical instability, with the community highlighting its strategic exposure to both U.S. giants and international defense leaders. Traders are closely monitoring the ETF's resilience and its concentrated positions in high-growth AI and defense-tech names as a play on long-term sector tailwinds.

Midnight is a privacy-first blockchain that blends public verifiability with confidential data handling. You can use Midnight's selective disclosure and ZK proofs to build apps.

Midnight

Midnight ($NIGHT) is generating significant community conversation as traders weigh the platform's focus on privacy-enhancing ZK proofs against concerns regarding its decentralization and high-profile partnerships. While some supporters highlight its potential within the Cardano ecosystem and its recent network milestones, others are actively debating its valuation, the impact of token airdrops on market stability, and ongoing legal scrutiny involving the project's early NFT initiatives.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending as investors gear up for the presentation of long-term Phase 3 VELA trial data at the upcoming American Academy of Dermatology (AAD) meeting, which is widely expected to validate sonelokimab as a best-in-class treatment for hidradenitis suppurativa. Community sentiment remains heavily bullish, with active discussions focusing on anticipated institutional accumulation, potential M&A activity involving major pharmaceutical suitors, and the company's path toward BLA submission later this year.

BlockDAG is a hybrid concept that combines features of both traditional blockchains and DAGs. It retains the benefits of DAGs, such as high scalability and faster transaction processing, while integrating the security and trust of blockchain consensus mechanisms. BlockDAG emerges as a groundbreaking solution, meticulously merging the strengths of both blockchain and DAG architectures. It leverages the robust security and decentralization of blockchains while incorporating the efficient, scalable transaction processing of DAGs. This strategic integration allows blockDAG to handle a significantly higher volume of transactions at faster speeds compared to traditional blockchains. By overcoming the inherent limitations of both technologies, blockDAG paves the way for a future where distributed ledgers can seamlessly scale to meet the ever-growing demands of the cryptocurrency and broader digital landscape.

BlockDAG

BlockDAG is currently facing intense scrutiny and widespread accusations of being a sophisticated scam, driven by severe community frustration over inaccessible tokens, failed claim processes, and suspicious exchange activity. Investors are actively debating the legitimacy of the project as they vent about missing balances, lack of functional contracts, and concerns that early access programs unfairly privilege insiders over retail participants.

Fidelity Wise Origin Bitcoin Fund - Fidelity Wise Origin Bitcoin Fund Beneficial Interest

Fidelity Wise Origin Bitcoin Fund

Fidelity Wise Origin Bitcoin Fund (FBTC) is seeing intense community engagement as investors debate its role as a strategic proxy for Bitcoin during a period of extreme market volatility and geopolitical uncertainty. The conversation is dominated by discussions on the fund's utility for tax-advantaged retirement accounts, the potential impact of long-term institutional accumulation, and the broader debate between holding spot assets in cold storage versus utilizing regulated ETFs.

Li Auto, Inc. engages in the design, development, manufacture, and sale of premium smart electric vehicles. Its products include Li MEGA, a high-tech flagship family MPV, Li L9, a six-seat flagship family SUV, and Li L8, a six-seat premium family SUV, and Li L7, a five-seat flagship family SUV. The firm also offers in-house development efforts on its proprietary range extension system, next-generation electric vehicle technology, and smart vehicle solutions. The company was founded by Xiang Li in April 2015 and is headquartered in Beijing, China.

Li Auto Inc - ADR

Li Auto is under intense pressure as investors weigh a disappointing Q2 earnings miss against a soft Q3 delivery outlook, fueling a broader sell-off in Chinese EV shares. The community is actively debating the company's competitive standing against peers like NIO, with heightened scrutiny on build quality, recent model performance, and fierce market share battles in the premium SUV segment.

Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.

Soleno Therapeutics Inc

Soleno Therapeutics is currently trending as investors monitor the upcoming PDUFA date for its Prader-Willi syndrome therapy, VYKAT XR, with significant interest focused on its potential commercial launch and market opportunity. Community discussions are heavily centered on analyzing clinical data, assessing the competitive landscape, and debating the stock's valuation as expectations for regulatory approval continue to drive volatility.

Starbucks Corp. engages in the production, marketing, and retailing of specialty coffee. It operates through the following segments: North America, International, and Channel Development. The North America segment focuses on the United States and Canada. The International segment is involved in China, Japan, Asia Pacific, Europe, Middle East, Africa, Latin America, and Caribbean. The Channel Development segment includes roasted whole bean and ground coffees, Seattle’s Best Coffee, and Teavana-branded single-serve products. The company was founded by Jerry Baldwin and Howard D. Schultz on November 4, 1985, and is headquartered in Seattle, WA.

Starbucks Corp.

Starbucks Corp

Starbucks is facing significant volatility as investors weigh the potential for a successful long-term turnaround against ongoing concerns regarding store closures, rising labor costs, and stiff competition from leaner, faster-growing rivals. The community is actively debating the effectiveness of the company's operational shift, with sentiment split between those accumulating shares on dips and skeptics who believe the brand is struggling to remain relevant in a tightening consumer environment.

Vanguard Index Funds - Vanguard Total Stock Market ETF

Vanguard Total Stock Market ETF

VTI is trending as investors weigh persistent geopolitical uncertainty and fiscal policy concerns against the broader strength of U.S. markets. Community discourse remains heavily polarized, with many users debating the impact of ongoing administration conflicts on long-term portfolio stability and the relative merits of broad index-based strategies versus active trading.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently in the spotlight as investors weigh the potential long-term revenue impact of its participation in the $185 billion Golden Dome missile defense system against broader market volatility and geopolitical uncertainty. The community remains heavily divided, with bulls pointing to the company's deepening integration into mission-critical defense infrastructure, while bears continue to challenge its high valuation and the sustainability of its growth trajectory amid a shifting political landscape.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

IR-Med, Inc. is engaged in the designing and developing devices utilizing spectrographic usability medical devices based on the combination of Infra-Red (IR) and Artificial Intelligence (AI) technologies. The company was founded by Ronnie Klein and Yaniv Cohen in April 2007 and is headquartered in Rosh Pinna, Israel.

IR-Med Inc

Peloswing

JFDI

ACInvestorBlog

GPaisa

A pillar of the Stocktwits ecosystem. This award recognizes the member who fosters connection, shares invaluable insights, and elevates the daily discussion to empower their fellow traders, on-platform.

Current Price	$0.0051
Prev Close	$0.001
Open	$0.0051
Dividend Yield	0.00%
50-Day Moving Average	$0.0052
Beta	-0.21
Avg. Volume	0.11
PE Ratio	-0.16

52-Week High	$0.48
52-Week Low	$0.001
Market Capitalization	$496,626.00
EPS (Annual)	-$0.027
Price to Book	-0.63
Revenue Per Employee	$0.00

IRME
IR-Med Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest IRME News

IRMEIR-Med Inc.